Home Cart Sign in  
Chemical Structure| 88206-46-6 Chemical Structure| 88206-46-6

Structure of Notopterol
CAS No.: 88206-46-6

Chemical Structure| 88206-46-6

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Notopterol induces apoptosis and inhibits cell cycle-specific, it's a natural product isolated and purified from the roots of Notopterygium incisum.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Notopterol

CAS No. :88206-46-6
Formula : C21H22O5
M.W : 354.40
SMILES Code : O=C1C=CC2=C(O1)C=C(OC=C3)C3=C2OC/C=C(C)/CC(O)/C=C(C)/C
MDL No. :MFCD23701669
InChI Key :BKIACVAZUKISOR-MKMNVTDBSA-N
Pubchem ID :5320227

Safety of Notopterol

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Mahlavu cells 30 µM 0, 24, 48 hours Treatment with 30 μM NOT significantly downregulated the expression levels of ATF4, p-JAK2, GPX1, CAT, and SOD1 proteins in Mahlavu cells. Nutrients. 2023 May 24;15(11):2447
HepJ5 cells 30 µM 0, 24, 48 hours Treatment with 30 μM NOT significantly downregulated the expression levels of ATF4, p-JAK2, GPX1, CAT, and SOD1 proteins in HepJ5 cells. Nutrients. 2023 May 24;15(11):2447
HL-60 cells 0, 5, 10, 20, 40 µM 2 weeks Notopterol significantly reduced the number of colonies formed by HL-60 cells. Drug Des Devel Ther. 2019 Jun 6;13:1927-1940
RAW264.7 cells 20 µM 24 hours Evaluate the ROS and NO scavenging ability of NBOP nanoparticles. Results showed that NBOP nanoparticles significantly reduced ROS and NO levels in LPS-stimulated macrophages. Acta Pharm Sin B. 2023 Dec;13(12):5016-5029
H9c2 cells 25 µM 24 hours To investigate the effect of Notopterol on uric acid-induced pyroptosis in H9c2 cells, results showed that notopterol inhibited uric acid-triggered proinflammatory cytokine production including IL-1β and IL-18. Pharmaceuticals (Basel). 2023 Feb 27;16(3):361
H9c2 cells 200 mg/L 24 hours To investigate the effects of uric acid on pyroptosis in H9c2 cells, results showed that uric acid stimulation increased NLRP3, caspase1, and cleaved caspase-1 p20 expression. Pharmaceuticals (Basel). 2023 Feb 27;16(3):361
A549 lung adenocarcinoma cells 0–100 µM 24, 48, 72 hours To evaluate the effect of Notopterol on the viability of A549 cells, results showed that Notopterol significantly reduced the viability of A549 cells in a dose- and time-dependent manner. Int J Mol Sci. 2023 Oct 11;24(20):15057
Mahlavu cells 0-100 µM 24, 48, 72 hours Notopterol significantly suppressed Mahlavu cell viability in a dose- and time-dependent manner. Treatment with 100 μM NOT for 24, 48, and 72 h resulted in a 39%, 60%, and 79% reduction in viability, respectively. Nutrients. 2023 May 24;15(11):2447
HepJ5 cells 0-100 µM 24, 48, 72 hours Notopterol significantly suppressed HepJ5 cell viability in a dose- and time-dependent manner. Treatment with 100 μM NOT for 24, 48, and 72 h resulted in a 33%, 49%, and 64% reduction in viability, respectively. Nutrients. 2023 May 24;15(11):2447
HL-60 cells 0, 10, 20, 40, 60, 80 µM 24-120 hours Notopterol inhibited the proliferation of HL-60 cells in a concentration-dependent manner. Drug Des Devel Ther. 2019 Jun 6;13:1927-1940
Human pulmonary arterial smooth muscle cells (HPASMCs) 5, 10, 20 µM 36 hours To evaluate the effect of Notopterol on the proliferation and migration of HPASMCs. Results showed that Notopterol significantly inhibited the proliferation and migration of HPASMCs under hypoxic conditions. Front Cardiovasc Med. 2022 Jun 3;9:859422
C28I2 5, 10, 20 µM 48 hours Notopterol significantly reduced IL-18 and TNF-α levels in inflamed cells, reduced ROS production post-inflammation, and inhibited the JAK2/STAT3 signaling pathway, thereby protecting chondrocytes from inflammation. Heliyon. 2024 Mar 13;10(6):e28094
C20A4 5, 10, 20 µM 48 hours Notopterol significantly reduced IL-18 and TNF-α levels in inflamed cells, reduced ROS production post-inflammation, and inhibited the JAK2/STAT3 signaling pathway, thereby protecting chondrocytes from inflammation. Heliyon. 2024 Mar 13;10(6):e28094
Normal human skin fibroblast cells 100 µM 48 hours To evaluate the effect of Notopterol on the viability of normal human skin fibroblast cells, results showed that Notopterol at 100 µM did not significantly affect cell viability. Int J Mol Sci. 2023 Oct 11;24(20):15057
HepJ5 cells 30 µM 48 hours After 48 h treatment with 30 μM NOT, HepJ5 cells transformed from elongated spindle-like to cuboid morphology. Nutrients. 2023 May 24;15(11):2447
HL-60 cells 0, 5, 10, 20, 40, 60 µM 48 hours Notopterol promoted apoptosis of HL-60 cells in a dose-dependent manner. Drug Des Devel Ther. 2019 Jun 6;13:1927-1940
Bone marrow monocytes (BMMs) 1, 2.5, 5, 10 µM 5 days Notopterol inhibits RANKL-activated osteoclast formation and bone resorption function by calculating tartrate resistant acid phosphatase (TRAcP) staining and hydroxyapatite resorption assays. Front Pharmacol. 2021 Jun 3;12:664836
HL-60 cells 1, 2.5, 5, 10, 25, 50, 100 µM 72 hours Notopterol significantly inhibited the growth of HL-60 cells with an IC50 value of 40.32 μM. Drug Des Devel Ther. 2019 Jun 6;13:1927-1940

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
C57BL/6 mice Ovariectomized (OVX) mouse model Intraperitoneal injection 10 mg/kg Every two days for 6 weeks Notopterol diminished the loss of bone mass in OVX mice by blocking osteoclastogenesis determined by bone histomorphometry, TRAcP staining and H&E staining. Front Pharmacol. 2021 Jun 3;12:664836
C57BL/6J mice Hyperuricemic mouse model Gavage 20 mg/kg Once daily for four weeks To investigate the effect of Notopterol on cardiac function in hyperuricemic mice, results showed that Notopterol improved exercise capacity and alleviated cardiac dysfunction in hyperuricemic mice. Pharmaceuticals (Basel). 2023 Feb 27;16(3):361
Male Sprague-Dawley rats Monocrotaline (MCT)-induced pulmonary arterial hypertension (PAH) model Intragastric administration 20 mg/kg/day Once daily for 3 weeks To evaluate the therapeutic effect of Notopterol on MCT-induced PAH rats. Results showed that Notopterol significantly reduced mortality, improved right ventricular function, decreased right ventricular systolic pressure (RVSP), alleviated right ventricular hypertrophy and fibrosis, and reduced pulmonary vascular remodeling and the expression of inflammatory factors (IL-1β and IL-6). Front Cardiovasc Med. 2022 Jun 3;9:859422
Wistar rats Collagen-induced arthritis (CIA) model Intravenous injection 5 mg/kg (Notopterol) and 15 mg/kg (BR-PEG/oPDA-PEG) Every three days for 30 days Evaluate the therapeutic efficacy of NBOP nanoparticles in the CIA model. Results showed that NBOP nanoparticles significantly alleviated arthritis symptoms, reduced joint swelling, and decreased inflammatory cytokine levels. Acta Pharm Sin B. 2023 Dec;13(12):5016-5029

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.82mL

0.56mL

0.28mL

14.11mL

2.82mL

1.41mL

28.22mL

5.64mL

2.82mL

References

 

Historical Records

Categories